US.EW · Edwards Lifesciences

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.0919590324689477,
        "turnoverUsdM": 210.74578668,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.EW",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 87.94,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 2,
        "rsi_score": 0.5,
        "macd_score": 3,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.2,
      "stop_loss_percent": 4.2,
      "take_profit_price": 96.369,
      "target_multiplier": 1.9,
      "technical_strength": 1.55,
      "take_profit_percent": 5
    },
    "positionPoints": 1.4,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.183918064937895,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 77.7,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 58.7,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 19
  },
  "market": {
    "ma20": 87.416,
    "ma50": 88.056,
    "close": 91.78,
    "prevClose": 90.82,
    "avgVolume20": 3394040,
    "volumeRatio": 0.68,
    "changePercent": 1.06
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 19,
    "details": {
      "ret_5d": 0.03823529411764692,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 19,
      "vcp_bonus": 0,
      "vol_ratio": 0.6516046737657584,
      "ret_points": 8,
      "vol_points": 0,
      "range_ratio": 1.0535867106985644,
      "volat_points": 0,
      "day_range_pct": 0.024187186750926234,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 8,
      "partial_history": false,
      "pullback_points": 0,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": true,
      "return_window_days": 5,
      "first_breakout_bonus": 2,
      "breakout_quality_points": 1
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 77.7,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.7,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 54,
        "contribution": 2.7
      },
      {
        "raw": 13.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 66,
        "contribution": 13.2
      },
      {
        "raw": 9.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 64,
        "contribution": 9.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.2,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 72,
        "contribution": 7.2
      },
      {
        "raw": 18,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 60,
        "contribution": 18
      },
      {
        "raw": 6,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 60,
        "contribution": 6
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 58.7,
    "details": [
      "基本面分析總分: 2.7/5分",
      "資金流分析總分: 13.2/20分",
      "市場環境分析總分: 9.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.2/10分",
      "技術信號分析總分: 18/30分",
      "情緒分析: 6/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.7,
      "資金流": 13.2,
      "市場環境": 9.6,
      "情緒分析": 6,
      "技術信號": 18,
      "風險管理": 7.2
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 2,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0.4,
          "turnoverUsdM": 210.74578668,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "一般",
        "items": {
          "cmfPoints": 2.4,
          "mfiPoints": 0.8,
          "obvPoints": 4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.EW",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 17.52
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 732.47650135,
                "ma50": 725.4243990000001,
                "name": "QQQ",
                "close": 725.60999,
                "points": 1.4
              },
              "spy": {
                "ma20": 770.8954959000001,
                "ma50": 767.6259946999999,
                "name": "SPY",
                "close": 772.31,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.0919590324689477,
          "atrPoints": 3,
          "cciPoints": 0.8,
          "vixPoints": 2.4,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "一般",
        "items": {
          "sentiment": {
            "score": 6,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 2,
              "negativeHits": 0,
              "positiveHits": 1,
              "sentimentScoreRaw": 1.2
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 143132433,
                "url": "https://finnhub.io/api/news?id=b913cc1f116b22cc2be45e9b6bd9d7b38f17ecce5afdecf6450e60f48867bf84",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences reported past FDA approvals for its PASCAL Precision system for tricuspid valve repair and PASCAL Ace with Capture Clarity for degenerative mitral TEER, giving the business a broader U.S. transcatheter repair toolkit for patients who are not good candidates for open heart surgery. The combination of tricuspid and mitral TEER approvals makes Edwards Lifesciences the only supplier offering both repair and replacement transcatheter options across these valves in the U.S.,...",
                "category": "company",
                "datetime": 1792754284,
                "headline": "Does Valve Repair Approval Change The Bull Case For Edwards Lifesciences (EW)?"
              },
              {
                "id": 143100621,
                "url": "https://finnhub.io/api/news?id=a8698f0719f543a45a3043e24bc1b0a6f9596a76ec9c66d43eab7060c8670246",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences' TMTT and TAVR growth, strong clinical evidence and solid balance sheet support expansion, but tariffs and currency headwinds threaten margins.",
                "category": "company",
                "datetime": 1792669680,
                "headline": "Is This the Right Time to Hold EW Stock in Your Portfolio?"
              }
            ],
            "raw_source": [
              {
                "id": 143260978,
                "url": "https://finnhub.io/api/news?id=45d5755dd23fee8ec644f7d9a45f3bd151afd89cf9e493a824cc4a015fab1666",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "PDEX heads into fiscal Q1 earnings with strong medical-device sales and margin momentum, but customer concentration, a shrinking backlog and acquisition risks loom.",
                "category": "company",
                "datetime": 1793200560,
                "headline": "ProDex Q1 Earnings Preview: Can Strong Sales Momentum Sustain Growth?"
              },
              {
                "id": 143260884,
                "url": "https://finnhub.io/api/news?id=e454def513df0abda0359afb6c3d0112e908665fea0440a7ad17847b5413a586",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "SYK's Q3 earnings may reflect strong hospital equipment demand and cybersecurity recovery, but supply constraints, vascular disruptions and margin pressures remain.",
                "category": "company",
                "datetime": 1793200560,
                "headline": "SYK Q3 Earnings: Can Recovery Momentum Offset Operational Headwinds?"
              },
              {
                "id": 143234634,
                "url": "https://finnhub.io/api/news?id=ce470b0cbb1f140b8cae1a6b8a3176382d7d1cb9919ad0dabc5f0f5f56412647",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "WST's Q3 earnings may benefit from strong HVP demand, biologics and GLP-1 growth, but West Vantage weakness and the SmartDose divestiture could weigh on sales.",
                "category": "company",
                "datetime": 1793104740,
                "headline": "WST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?"
              },
              {
                "id": 143234635,
                "url": "https://finnhub.io/api/news?id=0e4607bc059b5cfd75a7b897a7d87cefdfada8b2a0be0ff3fb2f87413a2c79dd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "GEHC heads into Q3 earnings with strong imaging demand and a record backlog, but PCS weakness, inflation and supply challenges could weigh on margins.",
                "category": "company",
                "datetime": 1793103780,
                "headline": "GEHC Ahead of Q3 Earnings: Can Strong Demand Offset Macro Headwinds?"
              },
              {
                "id": 143235270,
                "url": "https://finnhub.io/api/news?id=310fd3e075cf96b44c9f488691e9e1e1c855cdc24c90753fd5ec5d1f90cf5724",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/valuestock_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 1.24% on an annualized basis producing an average annual return of 14.27%. Currently, Edwards Lifesciences has a market capitalization",
                "category": "company",
                "datetime": 1793035814,
                "headline": "$100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today"
              },
              {
                "id": 143135911,
                "url": "https://finnhub.io/api/news?id=789c5f64f3f2cf7881b4b07392f83e9f63dfedf383c1ea91818187027101ec47",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Inspire Medical Systems gains 47.8% in three months as improved reimbursement clarity, an earnings beat, $30 million in annual savings and new CPT codes boost recovery prospects.",
                "category": "company",
                "datetime": 1792766220,
                "headline": "INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?"
              },
              {
                "id": 143132433,
                "url": "https://finnhub.io/api/news?id=b913cc1f116b22cc2be45e9b6bd9d7b38f17ecce5afdecf6450e60f48867bf84",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences reported past FDA approvals for its PASCAL Precision system for tricuspid valve repair and PASCAL Ace with Capture Clarity for degenerative mitral TEER, giving the business a broader U.S. transcatheter repair toolkit for patients who are not good candidates for open heart surgery. The combination of tricuspid and mitral TEER approvals makes Edwards Lifesciences the only supplier offering both repair and replacement transcatheter options across these valves in the U.S.,...",
                "category": "company",
                "datetime": 1792754284,
                "headline": "Does Valve Repair Approval Change The Bull Case For Edwards Lifesciences (EW)?"
              },
              {
                "id": 143136778,
                "url": "https://finnhub.io/api/news?id=5a5d111056252b2999b0ad4b505d9e30cec05621715a58d9d8440adabcce4679",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards’ approval should “strengthen the company’s position in the large and underpenetrated transcatheter tricuspid market,” analysts said.",
                "category": "company",
                "datetime": 1792750806,
                "headline": "Edwards wins FDA approval for tricuspid valve repair device"
              },
              {
                "id": 143103804,
                "url": "https://finnhub.io/api/news?id=62fd12e5080b12b6263d31d607a9f1b4d07b54f3d1d98dbe99a2fb7960637686",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "DaVita's 55.6% stock rally reflects stronger operating execution, improving treatment volumes and value-based kidney care gains despite reimbursement pressures.",
                "category": "company",
                "datetime": 1792690680,
                "headline": "DaVita Stock Gains 55.6% Year to Date: What's Behind the Rally?"
              },
              {
                "id": 143103803,
                "url": "https://finnhub.io/api/news?id=64e91c8c6fe34a2c1b6d7ffac246833155002d30dbbbee5bbf17bcba5d08f536",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "BD's 25.5% rally reflects stronger execution, portfolio reshaping, product innovation and U.S. manufacturing investments despite tariffs and cost pressures.",
                "category": "company",
                "datetime": 1792689660,
                "headline": "BDX Stock Gains 25.5% in Six Months: What's Behind the Rally?"
              },
              {
                "id": 143100621,
                "url": "https://finnhub.io/api/news?id=a8698f0719f543a45a3043e24bc1b0a6f9596a76ec9c66d43eab7060c8670246",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences' TMTT and TAVR growth, strong clinical evidence and solid balance sheet support expansion, but tariffs and currency headwinds threaten margins.",
                "category": "company",
                "datetime": 1792669680,
                "headline": "Is This the Right Time to Hold EW Stock in Your Portfolio?"
              },
              {
                "id": 143094387,
                "url": "https://finnhub.io/api/news?id=b2c85aa8df922e4873506e30b09daeb9bd72bff0ea48f981feb94a865d6e34f3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "The PASCAL Precision device is indicated to treat individuals with symptomatic severe tricuspid regurgitation.",
                "category": "company",
                "datetime": 1792660520,
                "headline": "Edwards secures FDA approval for tricuspid valve repair system"
              },
              {
                "id": 143067817,
                "url": "https://finnhub.io/api/news?id=b4575036babe3ca17c3d9b9b280784523ba14d92717883c8b9ffb333608060fd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "IRVINE, Calif., October 21, 2026--Edwards Lifesciences Corporation (NYSE: EW) today announced that the U.S. Food and Drug Administration (FDA) has approved its PASCAL Precision system for tricuspid valve repair. The system is indicated for improving quality of life and functional status in patients with symptomatic severe tricuspid regurgitation (TR) despite optimal medical therapy who are deemed at intermediate or greater risk for surgery and deemed appropriate for transcatheter edge-to-edge tr",
                "category": "company",
                "datetime": 1792587600,
                "headline": "FDA Approval of Edwards Lifesciences’ PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease"
              },
              {
                "id": 143067541,
                "url": "https://finnhub.io/api/news?id=81838d297dff31d72c83688080f0c7fe609014e55d3a8995b53e4433356df155",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "ISRG's Q3 2026 earnings beat estimates as strong system placements, rising procedure volumes and improving margins fuel double-digit revenue growth.",
                "category": "company",
                "datetime": 1792585980,
                "headline": "Intuitive Surgical's Q3 Earnings Beat Estimates on Strong System Sales"
              },
              {
                "id": 143067057,
                "url": "https://finnhub.io/api/news?id=c52e0234621653156fb737978b4b17fc182b84f9ed2c5c3bcd798f931671d143",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_2.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1792503310,
                "headline": "9 Health Care Stocks Whale Activity In Today’s Session"
              },
              {
                "id": 142950181,
                "url": "https://finnhub.io/api/news?id=96549fc3169af14a5b37e1838856ce6d4ea231da47ab79fb2b1b643ba4673a05",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "The U.S. Food and Drug Administration (FDA) issued a high-risk early alert after Edwards Lifesciences Corp. (NYSE:EW) recalled specific lots of its Commander M delivery systems due to reports of balloons bursting during procedures, resulting in one death and a serious injury. Recall Of Commander M Delivery Systems The delivery systems help implant a replacement mitral heart valve through blood vessels, bypassing the need for open-chest surgery. However, the company received three distinct report",
                "category": "company",
                "datetime": 1792163582,
                "headline": "FDA Flags High-Risk Heart Device Recall At Edwards Lifesciences After Patient Death"
              },
              {
                "id": 142945843,
                "url": "https://finnhub.io/api/news?id=efc985c8849482b1c5cb63a903feab7a147146983249315764c2b32ff17b12da",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "An issue with the delivery component of Edwards’ SAPIEN M3 TMVR system has been associated with one patient death and one serious injury as of 5 October.",
                "category": "company",
                "datetime": 1792151246,
                "headline": "Edwards’ SAPIEN M3 delivery system linked to patient death in FDA alert"
              },
              {
                "id": 142947552,
                "url": "https://finnhub.io/api/news?id=cce961828583081443d280e38e71db1b045f33b20765ffc7c43f7023022e5860",
                "image": "",
                "source": "Benzinga",
                "related": "EW",
                "summary": "https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-transcatheter-mitral-valve-delivery-system-issue-edwards-lifesciences ",
                "category": "company",
                "datetime": 1792122647,
                "headline": "Reported Earlier, Edwards Lifesciences Tells Customers To Remove Four Lots Of Commander M Delivery Systems For SAPIEN M3; FDA Flags Potentially High-Risk Issue"
              },
              {
                "id": 142882630,
                "url": "https://finnhub.io/api/news?id=5e4289c0c9b96dfa1e95a00694f6be0915f8672c2b831308bed3a3fce09f0551",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "With the US population aging rapidly, three healthcare ETFs offer exposure to companies developing treatments, drugs and medical devices for age-related conditions.",
                "category": "company",
                "datetime": 1791979740,
                "headline": "Bet on These Healthcare ETFs to Benefit From the Aging US Population"
              },
              {
                "id": 142821843,
                "url": "https://finnhub.io/api/news?id=5b892fbff9720a6bd56b824deb05c3dc8dcd697cd77783988b10fb0eaab315fb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Edwards Lifesciences is set to report its Q3 earnings next month, with analysts expecting single-digit year-over-year EPS growth.",
                "category": "company",
                "datetime": 1791795397,
                "headline": "Edwards Lifesciences Earnings Preview: What to Expect"
              },
              {
                "id": 142730419,
                "url": "https://finnhub.io/api/news?id=5741fde32d2d428cfb091510e2b9dc970e9a9cdc9798a0a9de13df26fb600389",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "EW",
                "summary": "Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.",
                "category": "company",
                "datetime": 1791477301,
                "headline": "Stay informed with the top movers within the S&P500 index on Thursday."
              },
              {
                "id": 142703057,
                "url": "https://finnhub.io/api/news?id=cbb9c770540f123bf7f8169895da328689f42faa5286fda4eeaa46990dd6c523",
                "image": "",
                "source": "Fintel",
                "related": "EW",
                "summary": "",
                "category": "company",
                "datetime": 1791417130,
                "headline": "Barclays Initiates Coverage of Edwards Lifesciences at Overweight"
              },
              {
                "id": 142699429,
                "url": "https://finnhub.io/api/news?id=c7662009b9ace98cff37eb649fd5c094fe1d8023fc1a1ff779048499c9832520",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Intuitive Surgical SP platform is gaining momentum as procedures, utilization and placements rise, with expanding indications and global adoption fueling growth.",
                "category": "company",
                "datetime": 1791394260,
                "headline": "Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise?"
              },
              {
                "id": 140420211,
                "url": "https://finnhub.io/api/news?id=c9045c53ac19ad80d94a07c2e8320fa134ac76c18ad5824d79898864952688d5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "Intel downgraded, Marvell upgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1791381613,
                "headline": "Intel downgraded, Marvell upgraded: Wall Street's top analyst calls"
              },
              {
                "id": 142689571,
                "url": "https://finnhub.io/api/news?id=7328d68ff960ea6cd6cc1d7e84ad93210c84e804ca09c005e1de805c1458a6df",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "IRVINE, Calif., October 07, 2026--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended Sept. 30, 2026 after the market closes on Wednesday, Nov. 4, and will host a conference call at 5:00 p.m. ET that day to discuss those results.",
                "category": "company",
                "datetime": 1791367200,
                "headline": "Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026"
              },
              {
                "id": 142696722,
                "url": "https://finnhub.io/api/news?id=b571dd0f7ba78a624d470fa3b3093c847514e128ce54822d2c1d0f3490f79271",
                "image": "",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Barclays  analyst Christopher Pasquale   initiates coverage on Edwards Lifesciences (NYSE:EW) with a Overweight rating and announces Price Target of $110.",
                "category": "company",
                "datetime": 1791362408,
                "headline": "Barclays Initiates Coverage On Edwards Lifesciences with Overweight Rating, Announces Price Target of $110"
              },
              {
                "id": 142632289,
                "url": "https://finnhub.io/api/news?id=5e79a351c69253cee95dc15b7a09a3b5363e19ef80d37e125eab80d72c621996",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "IRVINE, Calif., October 05, 2026--Edwards Lifesciences (NYSE: EW) today announced that it will host an investor event in conjunction with the TCT annual scientific symposium in San Diego on Monday, Nov. 2, from 5:00 to 6:00 PM Pacific Time. The meeting will include a live Q&A session with physicians and members of the Edwards management team.",
                "category": "company",
                "datetime": 1791194400,
                "headline": "Edwards Lifesciences to Host Investor Event in Conjunction With TCT"
              },
              {
                "id": 142614627,
                "url": "https://finnhub.io/api/news?id=8655f8ec1bb477449776d78501af9ab82fe6b743d6ab33f1f8d7997fe0bbe8ef",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/02/Doctors--Tablet-And-People-With-Discussi.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Edwards Lifesciences earned FDA approval for its AUTUS pediatric heart valve, designed to expand as young patients grow.",
                "category": "company",
                "datetime": 1790937962,
                "headline": "Edwards Lifesciences Secures FDA Approval for First Expandable Pediatric Heart Valve"
              },
              {
                "id": 142589114,
                "url": "https://finnhub.io/api/news?id=80eebecc20b73e3685f3c3092f41f338a5253af972377b06c0dc5ce304802ac8",
                "image": "https://cdn.benzinga.com/files/images/story/2026/10/02/Bangkok--Thailand---July-2--2017nike-Cla.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Nike falls on weak revenue; Synaptics jumps on $123 ON deal; AsiaStrategy surges on tokenization pact; Mangoceuticals drops.",
                "category": "company",
                "datetime": 1790914563,
                "headline": "Nike, Synaptics And 3 Stocks To Watch Heading Into Friday"
              },
              {
                "id": 142563009,
                "url": "https://finnhub.io/api/news?id=b0ab83642594294ce72c45514fe4296905c2602deb7307b9dddd9eaf37adf90a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "EW",
                "summary": "IRVINE, Calif., October 01, 2026--Edwards Lifesciences (NYSE: EW) today announced that the U.S. Food and Drug Administration (FDA) has approved the AUTUS Size-Adjustable Valve, a surgical pulmonary valve designed specifically for pediatric patients with congenital heart disease who require pulmonary valve replacement.",
                "category": "company",
                "datetime": 1790886360,
                "headline": "Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients"
              },
              {
                "id": 142590120,
                "url": "https://finnhub.io/api/news?id=17619dfabefb34c722fa720a4545f003a4542ab1a2e12bc371a4dd0e88326aff",
                "image": "",
                "source": "Benzinga",
                "related": "EW",
                "summary": "Edwards Lifesciences (NYSE:EW) today announced that the U.S. Food and Drug Administration (FDA) has approved the AUTUS Size-Adjustable Valve, a surgical pulmonary valve designed specifically for pediatric patients with",
                "category": "company",
                "datetime": 1790872027,
                "headline": "Edwards Lifesciences Says FDA Approves AUTUS Size-Adjustable Valve, Surgical Pulmonary Valve Designed For Pediatric Patients With Congenital Heart Disease"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 2,
            "negative_hits": 0,
            "positive_hits": 1,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.2,
            "source_article_count": 31,
            "discarded_article_count": 29
          },
          "sentimentPoints": 6
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 18,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 2.4000000000000004,
          "vcpPoints": 0.9,
          "macdPoints": 4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 0.9,
            "vcp_reason": "站上MA50；收盤突破20日高位；Ready=N；Confirm=Y",
            "vcp_metrics": {
              "up_days": 7,
              "vol_ref": 3606963.3333333335,
              "down_days": 2,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 3250440,
              "avg_vol_20": 3523925,
              "avg_vol_30": 3606963.3333333335,
              "range_pct_10": 0.0708215297450425,
              "range_pct_20": 0.09697101765090424,
              "range_pct_30": 0.09697101765090424,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": false,
              "down_shrink_ok": false,
              "up_expand_days": 1,
              "breakout_20d_ok": true,
              "vol_ratio_10_30": 0.9011569288662947,
              "dist_to_20d_high": -0.004927187123617682,
              "down_shrink_days": 1,
              "breakout_level_20d": 91.33,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.7303370786516862
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": false
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 0.4
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.0919590324689477,
              "turnoverUsdM": 210.74578668,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.EW",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 87.94,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 2,
              "rsi_score": 0.5,
              "macd_score": 3,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.2,
            "stop_loss_percent": 4.2,
            "take_profit_price": 96.369,
            "target_multiplier": 1.9,
            "technical_strength": 1.55,
            "take_profit_percent": 5
          },
          "positionPoints": 1.4,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.183918064937895,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 78.57,
    "atr": {
      "atr": 1.92,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.09
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": 161.57
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "輕微流入",
      "score": 6,
      "value": 0.1928
    },
    "kdj": {
      "d": 85.47,
      "j": 97.49,
      "k": 89.48,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 83.49
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 10,
      "trend": "強流入",
      "value": 26966606,
      "recentSlope": 1186550.6,
      "previousSlope": -21680
    },
    "rsi": 75.44,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 8,
      "trend": "上升",
      "value": 83.7337,
      "position": "SAR喺價下",
      "distancePct": 8.77,
      "previousTrend": "上升"
    },
    "ma50": 88.056,
    "macd": {
      "macd": 0.8938879757108111,
      "trend": "強烈看漲",
      "signal": 0.26650817501699653,
      "histogram": 0.6273798006938146
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 87.0063,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 10
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "空升",
      "ratio": 0.68,
      "score": 2,
      "avgVolume": 3394040,
      "currentVolume": 2296206
    },
    "derived": {
      "ma20": 87.416,
      "ma50": 88.056,
      "prevClose": 90.82,
      "avgVolume10": 3076421,
      "avgVolume20": 3394040,
      "changePercent": 1.06,
      "avgVolumeForScore": 3394040
    },
    "ma_cross": {
      "ma20": 87.416,
      "ma50": 88.056,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 87.143,
      "prevMa50": 88.04,
      "spreadPct": 0.73,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 83.2082,
      "upper": 91.6238,
      "position": "上半部"
    },
    "rsi_short": 81.56,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.68
    }
  }
}

{
  "close": 91.78,
  "volume": 2296206,
  "changePercent": 1.06
}